Artículos de revistas
Efficacy And Safety Of Sultamicillin (ampicillin/sulbactan) And Amoxicillin/clavulanic Acid In The Treatment Of Upper Respiratory Tract Infections In Adults - An Open-label, Multicentric, Randomized Trial [eficácia E Segurança De Sultamicilina (ampicilina/sulbactam) E Amoxacilina/clavulanato No Tratamento Das Infecções De Via Aéreas Superiores Em Adultos - Um Estudo Multicêntrico, Aberto E Randomizado]
Registro en:
Revista Brasileira De Otorrinolaringologia. , v. 72, n. 1, p. 104 - 111, 2006.
347299
2-s2.0-33747429783
Autor
Ferreira J.B.
Rapoport P.B.
Sakano E.
Kos A.O.D.A.
Piltcher O.B.
Pignatari S.S.N.
Pinheiro S.D.
Mocellin M.
Institución
Resumen
Upper respiratory tract infections are the most common causes of medical visits in children and adults, demanding massive use of antibiotics. Bacterial resistance caused by beta-lactamase is one of the most serious problems in this matter. Sultamicillin, a double pro-drug of Ampicillin/Sulbactan, is a potent beta-lactamase inhibitor which can face this challenge. Aim: evaluate efficacy, safety and tolerability of Ampicillin/Sulbactan compared to Amoxicillin/ Clavulanate in upper respiratory tract infections in adults. Methods: 102 patients were enrolled and randomized to receive Ampicillin/Sulbactan or Amoxicillin/Clavulanate during 10 days. They were evaluated 10 and 30 days after treatment to learn about the therapeutic response. Results: There were no differences between the two groups respecting cure at the end of treatment (visit 2) or at the end of the study (visit 3). Cure ratio was 61.7% and 93.2% (visits 2 and 3) in the Amoxicillin/Clavulanate group compared to 64.4% and 97.4%, respectively, in Ampicillin/Sulbactan group. The adverse events ratio for the two groups was the same (p=0.940). The number of patients with diarrhea was greater in the group of patients receiving Amoxicillin/Clavulanate (70.6%) than in the group receiving Ampicillin/Sulbactan (29.4%) (p=0.0164). Conclusions: Ampicillin/Sulbactan is as safe and efficient as Amoxicillin/Clavulanate in the empiric treatment of upper respiratory infections in adults. The low occurrence of diarrhea in the group receiving Ampicillin/Sulbactan needs confirmation in other studies. 72 1 104 111 Diagnosis and management of acute otitis media (2004) Pediatrics, 113 (5), pp. 1451-1465 Snow, V., Mottur-Pilson, C., Cooper, R.J., Hoffman, J.R., Principles of appropriate antibiotic use for acute pharyngitis in adults (2001) Ann Intern Med, 134 (6), pp. 506-508 Snow, V., Mottur-Pilson, C., Hickner, J.M., Principles of appropriate antibiotic use for acute sinusitis in adults (2001) Ann Intern Med, 134 (6), pp. 495-497 Snow, V., Mottur-Pilson, C., Gonzales, R., Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults (2001) Ann Intern Med, 134 (6), pp. 487-489 Rosenfeld, R.M., Otitis, antibiotics, and the greater good (2004) Pediatrics, 114 (5), pp. 1333-1335 Webb, K.H., Needham, C.A., Kurtz, S.R., Use of a high-sensitivity rapid strep test without culture confirmation of negative results 2 years' experience (2000) J Fam Pract, 49 (1), pp. 34-38 Needham, C.A., McPherson, K.A., Webb, K.H., Streptococcal pharyngitis impact of a high-sensitivity antigen test on physician outcome (1998) J Clin Microbiol, 36 (12), pp. 3468-3473 Webb, K.H., Does culture confirmation of high-sensitivity rapid streptococcal tests make sense? a medical decision analysis (1998) Pediatrics, 101 (2), pp. E2 Pitrez, P.M., Pitrez, J.L., Acute upper respiratory tract infections outpatient diagnosis and treatment (2003) J Pediatr, 79 (1 SUPPL.), pp. S77-S86. , Rio J Talan, D.A., Moran, G.J., Pinner, R.W., Progress toward eliminating Haemophilus influenzae type b disease among infants and children - United States, 1987-1997 (1999) Ann Emerg Med, 34 (1), pp. 109-111 O'Brien, T.F., Resistance of bacteria to antibacterial agents report of task force 2 (1987) Rev Infect Dis, (3 SUPPL.), pp. S244 Moosdeen, F., Keeble, J., Williams, J.D., Induction/inhibition of chromosomal b-lactamases by b-lactamase inhibitors (1986) Rev Infect Dis, 8 (5), pp. S562-S568 Acar, J.F., Gutmann, L., Kitzis, M.D., Beta-lactamases in clinical isolates Spectrum implications of sulbactam/ampicillin (1988) Drugs, 35 (7 SUPPL.), pp. 12-16 Jones, R.N., Dudley, M.N., Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam analysis of the correlations between in vitro test results and clinical response (1997) Diagn Microbiol Infect Dis, 28 (1), pp. 5-18 Lode, H., Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections (2001) Int J Antimicrob Agents, 18 (3), pp. 199-209 Bello, H., Dominguez, M., Gonzalez, G., Zemelman, R., Mella, S., Young, H.K., In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus- Acinetobacter baumannii complex isolated in Chile between 1990 and 1998 (2000) J Antimicrob Chemother, 45 (5), pp. 712-713 Cisterna, R., Fresnadillo, M.J., Garcia-Rodriguez, J.A., Gobernado, M., Martin, R., Perea, E., Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae (1998) Rev Esp Quimioter, 11 (3), pp. 245-250 Okimoto, N., Kurihara, T., Honda, N., Asaoka, N., Fujita, K., Ohba, H., Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly (2003) J Infect Chemother, 9 (2), pp. 183-186 Alpuche-Aranda, C.M., Beta-lactamase production and the role of ampicillin/sulbactam (1998) Pediatr Infect Dis J, 17 (3 SUPPL.), pp. S8-11 Arredondo-Garcia, J.L., Use of ampicillin/sulbactam (sultamicillin) in the management of pediatric infections. Introduction (1998) Pediatr Infect Dis J, 17 (3 SUPPL.), pp. S3 Lopez, E.L., Rivas, N.A., Clinical use of sultamicillin (ampicillin/sulbactam) in children (1998) Pediatr Infect Dis J, 17 (3 SUPPL.), pp. S12-S14 Adam, D., Beta-lactam antibiotics their role in the management of infections in children (1998) Pediatr Infect Dis J, 17 (3 SUPPL.), pp. S4-S7 Kanra, G., Experience with ampicillin/sulbactam in severe infections (2002) J Int Med Res, 30 (1 SUPPL.), pp. 20A-30A Adam, D., Beta-lactam/beta-lactamase inhibitor combinations in empiric management of pediatric infections (2002) J Int Med Res, 30 (1 SUPPL.), pp. 10A-19A Zhu, X.L., Wong, W.K., Yeung, W.M., Mo, P., Tsang, C.S., Pang, K.H., A randomized, double-blind comparison of ampicillin/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgery (2001) Clin Ther, 23 (8), pp. 1281-1291 Allewelt, M., Schuler, P., Bolcskei, P.L., Mauch, H., Lode, H., Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess (2004) Clin Microbiol Infect, 10 (2), pp. 163-170 Geckler, R., A comparison of ampicillin/sulbactam and cefuroxime in the treatment of patients with bacterial infections of the lower respiratory tract (1994) Clin Ther, 16, pp. 662-672 Weigelt, J.A., A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections (1994) Adv Ther, 11, pp. 183-191 Bluestone, C.D., Role of sulbactam/ampicillin in the treatment of bacterial infections of the upper respiratory tract of children (1987) "Sulbactam Worldwide Clinical Experience", 15th International Congress of Chemotherapy, , Istanbul, Turkey, July 21 Gilbert, D.N., Moellering Jr., R.C., Sande, M.A., The Sanford "Guia para Terapêutica Antimicrobiana" 33 a Edição 2003/2004 Em Português, , EPUC. São Paulo